CILOSTAHEAL 100

Cilostaheal-100 is formulated with 100 mg of Cilostazol, a therapeutic agent indicated for the management of intermittent claudication. This condition manifests as discomfort or pain in the legs during physical exertion, primarily due to inadequate blood circulation. Cilostazol’s mechanism of action involves enhancing blood flow by preventing platelet aggregation, which in turn dilates blood vessels. By improving circulation, this medication aids in alleviating symptoms associated with peripheral artery disease, thereby promoting an increased walking distance and overall enhancement in quality of life for individuals suffering from this vascular issue. Cilostaheal-100 is commonly included in a holistic treatment regimen tailored to address circulation-related symptoms effectively. Patients are encouraged to follow their healthcare provider’s instructions regarding dosage and administration, while also monitoring their response to the medication. Regular follow-up appointments may be necessary to evaluate the effectiveness and to make any adjustments in treatment as needed. As with any medication, it is critical for patients to disclose their complete medical history, including any other medications they are taking, to ensure safe and effective use of Cilostaheal-100. Use this medicine only under medical supervision. Follow the dose and schedule exactly as advised. Do not stop abruptly without guidance. Keep a record of any unusual symptoms and share them with your clinician. Combine therapy with appropriate lifestyle measures and routine monitoring as recommended.